Use of interleukin-1 conjugates in the treatment of diabetes

Details for Australian Patent Application No. 2009221114 (hide)

Owner Cytos Biotechnology AG

Inventors Spohn, Gunther; Bachmann, Martin

Agent Watermark

Pub. Number AU-A-2009221114

PCT Pub. Number WO2009/109643

Priority 08152336.7 05.03.08 EP

Filing date 5 March 2009

Wipo publication date 11 September 2009

International Classifications

C07K 14/545 (2006.01) Peptides having more than 20 amino acids

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/109643 Priority application(s): WO2009/109643

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221120-Improved antitumoral treatments

2009221106-Novel antigen binding dimer-complexes, methods of making and uses thereof